Neonatal Screening Systems
Neonatal screening is used to detect in babies congenital diseases that are treatable only when identified during the first days of life. PerkinElmer supplies all of the products needed to establish and maintain an effective screening program.
View Technology
PerkinElmer’s Neonatal17 a-OH-Progesterone (17OHP) assay for its DELFIA®, AutoDELFIA® and GSP®... View more
High performance, reliable CHscreening toolsThe analytical sensitivity of PerkinElmer’sNeonatal TSH ... View more
Now available - automated Toxoplasma gondii IgM immunoassay for neonatal screening of congenital toxoplasmosisPerkinElmer’s... View more
Top performance based onrobust DELFIA® chemistryThe Neonatal IRT assay provides highanalytical sensitivity... View more
The incidence of galactosemia is 1:14000 – 1:60000. The untreated disorder will cause poor development,... View more
PerkinElmer platforms for dried blood spot assays include the GSP Genetic Screening Processor and the... View more